31,878 Shares in Heartflow, Inc. $HTFL Bought by Bcwm LLC

Bcwm LLC purchased a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 31,878 shares of the company’s stock, valued at approximately $935,000.

Other large investors have also added to or reduced their stakes in the company. XXEC Inc. bought a new position in shares of Heartflow during the second quarter valued at about $2,524,764,000. Sei Investments Co. grew its stake in shares of Heartflow by 342.5% in the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after purchasing an additional 51,895 shares during the last quarter. Quantinno Capital Management LP purchased a new position in Heartflow during the 1st quarter valued at about $1,734,000. Handelsbanken Fonder AB purchased a new position in Heartflow during the 2nd quarter valued at about $910,000. Finally, Walleye Capital LLC bought a new position in Heartflow during the 2nd quarter valued at approximately $8,760,000.

Insider Activity at Heartflow

In other Heartflow news, CEO John C.M. Farquhar sold 27,230 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the completion of the transaction, the chief executive officer owned 360,814 shares of the company’s stock, valued at approximately $18,040,700. This trade represents a 7.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the sale, the insider owned 86,459 shares in the company, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 191,271 shares of company stock worth $7,089,136 over the last 90 days. 7.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Wells Fargo & Company upped their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Canaccord Genuity Group raised their price target on Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Benchmark reissued a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Robert W. Baird set a $45.00 price objective on shares of Heartflow in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Heartflow Stock Performance

Heartflow stock opened at $48.94 on Thursday. The stock’s 50 day simple moving average is $31.68 and its two-hundred day simple moving average is $28.79. The stock has a market cap of $4.26 billion and a price-to-earnings ratio of -26.74. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.19.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm had revenue of $64.08 million for the quarter. The company’s revenue for the quarter was up 47.7% on a year-over-year basis. On average, analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.